Ulobetasol
From Wikipedia, the free encyclopedia
|
Ulobetasol
|
|
| Systematic (IUPAC) name | |
| (6S,8S,9S,10S,11S,13S,14S,16S,17R)-17-(2-Chloroacetyl)- 6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl- 6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one | |
| Identifiers | |
| CAS number | |
| ATC code | D07 |
| PubChem | |
| Chemical data | |
| Formula | C22H27ClF2O4 |
| Mol. mass | 428.897 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Ulobetasol (or halobetasol) is a corticosteroid.

